Video

VIDEO: Consistency is key to monitoring patients on opioids


 

EXPERT ANALYSIS FROM PAIN CARE FOR PRIMARY CARE

References

ORLANDO – Take a consistent approach with all patients on opioid therapy, regardless of a patient’s perceived potential for abuse, Dr. Melissa B. Weimer advised.

“This is an area of medicine where I feel we need to apply universal precautions to all patients,” noted Dr. Weimer, assistant professor of medicine, Oregon Health and Science University, Portland. “We’re treating all patients as at some level of potential harm from this medication.”

In an interview at a meeting held by the American Pain Society and Global Academy for Medical Education, Dr. Weimer outlined a strategy that employs the same protocol to monitor therapy, even when the abuse potential is considered to be low.

Global Academy and this news organization are owned by the same company. Dr. Weimer reported no financial disclosures.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Rise in reports of pain, depression in last year of life in oncology patients
MDedge Hematology and Oncology
Abuse-deterrent formulation of extended-release hydrocodone approved
MDedge Hematology and Oncology
More than 75% with sickle cell crises don’t get hydroxyurea
MDedge Hematology and Oncology
ICOO: Opioid self-dosing falls short of pain control
MDedge Hematology and Oncology
ICOO: Massachusetts governor takes on opioid epidemic
MDedge Hematology and Oncology
ICOO: Quality metrics needed for medical marijuana
MDedge Hematology and Oncology
Only moderate-quality evidence supports medical cannabinoids
MDedge Hematology and Oncology
PCPC: Avoid these traps when prescribing medical marijuana
MDedge Hematology and Oncology
Hydroxyurea boosts O2 saturations in children with sickle cell disease
MDedge Hematology and Oncology
VIDEO: Use fiduciary duty to set pain medication boundaries
MDedge Hematology and Oncology